Pilot Study to Determine Safety and Efficacy of Orbital Injections of LIPO-102 in Patients With Symptomatic Exophthalmos Associated With Thyroid-related Eye Disease (TED)

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions

Thyroid-Related Eye Disease

Interventions

DRUG

LIPO-102

intraorbital injection

DRUG

Placebo

intraorbital injection

Trial Locations (5)

Adelaide

Brisbane

Melbourne

Sydney

Auckland